CEO presentation today to institutional investors...LEP-ETU and LE-DT enrollment to be completed this quarter...also displayed Pulmonary Fibrosis slides...concluded by showing some financial slides with one showing cash of 13.X Mil....several drugs in development and a phase II will be coming to an end.....expect PR's on a variety of compounds...two in particular...they have started a confirmatory phase III...so things are getting close...they are seeking partnership and/or out-licencing at this time
Share This Post:
***The above post constitutes a buy or sell recommendation dependent upon my stated position. I am not a licensed broker but, several people have told me that I look good in a suit. If its entertainment you want, I suggest watching CNBC and/or hiring a licensed broker.